Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Dermatol Surg ; 46(2): 169-179, 2020 02.
Article in English | MEDLINE | ID: mdl-31274530

ABSTRACT

BACKGROUND: Leg ulcers that do not heal despite appropriate treatment are defined as recalcitrant ulcers. Large surface area, depth, and long duration represent some of most important factors impeding ulcer healing. After sharp debridement, dermal substitutes including skin from cadaver donors may increase the healing rate of recalcitrant ulcers reducing the risk of scar formation and recurrence. OBJECTIVE: Assessing if, after sharp debridement, dermal substitutes including skin from cadaver donors may increase the healing rate of recalcitrant ulcers reducing the risk of scar formation and recurrence. PATIENTS AND METHODS: Among patients admitted to our hospital for all types of chronic leg ulcers, we retrospectively reviewed the records of patients affected by recalcitrant ulcers (surface greater than 100 cm, tissue loss involving epidermis, dermis, and subcutaneous tissue, duration longer than 1 year, and showing no healing tendency). After sharp debridement, the ulcers were covered by allografts with strict follow-up after discharge. Multiple allografts were performed when necessary, and a final autograft was applied in case of incomplete healing. RESULTS: The records of 414 patients were analyzed. Forty-three patients were lost at follow-up, and the remaining 371 healed after 765 grafting procedures. In 163 patients, the ulcers healed by means of a final autograft. In all the remaining cases, allograft led to ulcer healing. CONCLUSION: Allografts represent an effective treatment option in case of recalcitrant, large, deep and long-lasting leg ulcers.


Subject(s)
Allografts/transplantation , Leg Ulcer/surgery , Skin Transplantation , Wound Healing , Aged , Aged, 80 and over , Autografts/transplantation , Cadaver , Chronic Disease , Debridement , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome
2.
J Wound Care ; 27(12): 816-821, 2018 12 02.
Article in English | MEDLINE | ID: mdl-30557114

ABSTRACT

OBJECTIVE: To assess the tolerability and efficacy of photodynamic therapy (PDT) with RLP068, a novel phthalocyanine-derived photosensitiser, in controlling the bacterial load in different leg ulcers, due to vascular pathophysiology. METHOD: An observational study of patients with infected leg ulcers of different pathophysiology, admitted to the hospital for a skin grafting procedure, were included. All patients underwent two sessions of PDT at time zero and after 72 hours. A semi-quantitative swab was taken before and 30 minutes after both sessions of PTD. During the time interval between the two treatments the ulcer was covered with foam dressing and compression therapy was applied to all patients. No systemic or topical antibiotics were administered. Statistical analysis of results was performed. RESULTS: A total of 36 patients (13 males, 23 females; aged 72.4±8.6 years, range: 55-85 years) were recruited; two had ulcers on both legs. PDT was shown to be effective in reducing bacterial load after the first treatment. Before the second PDT treatment (72 hours after first PDT treatment), a slight increase of the bacterial load was observed in all ulcers. However, after the second PDT session, bacterial swab results were negative in all but two ulcers. The procedure was well tolerated in all but four patients, who reported a very severe pain at baseline, which increased during treatment. CONCLUSION: In this study, PDT was effective in reducing bacterial load in patients with infected vascular leg ulcers, and allowed successful skin grafting to take place in all patients. The treatment was generally well tolerated. Studies with a greater number of patients and a control group are planned to confirm these results.


Subject(s)
Bacterial Load/drug effects , Indoles/therapeutic use , Leg Ulcer/drug therapy , Photochemotherapy/methods , Radiation-Sensitizing Agents/therapeutic use , Varicose Ulcer/drug therapy , Aged , Aged, 80 and over , Female , Humans , Isoindoles , Male , Middle Aged , Pilot Projects , Treatment Outcome
3.
Minerva Cardioangiol ; 64(4 Suppl 2): 1-80, 2016 Aug.
Article in Italian | MEDLINE | ID: mdl-27713392

ABSTRACT

Phlebology is not a specialty for its own in Italy. Phlebological patients are treated by vascular and general surgeons, dermatologists, phlebologists, angiologists, internists and even general practitioners. Even tough guidelines present a series of recommendations based on evidence-based medicine, guidelines may also be a tool to unify the diagnostic and therapeutic approach in a vast medical field like phlebology. Since vascular surgeons and phlebologists are particularly involved in phlebology-related pathologies the scientific societies of the Italian Society of Phlebology (SIF) and the Italian Society for Vascular and Endovascular Surgery (SICVE) decided to cooperate for the preparation of phlebo-lymphological guidelines. These guidelines comprehend also an important chapter dealing with the lymphology of the lower extremities; phlebological active physicians are often faced with lymphatic pathologies and a good differential diagnosis can be sometimes very helpful. Sclerotherapy and Surgery as the major therapeutical alternatives are extensively analyzed, but also the compression therapy, the medical and physical therapy are presented under the critical view of evidence based analyses. Separate chapters deal with the treatment alternatives for superficial and deep venous thromboses and the recommendations for the treatment of venous ulcers. The current scientific evidences were confronted with the experiences of Italian specialists and the particular practice and reality in Italy. They represent therefore the actual valid positions and recommendations in Italy which shall be updated regularly.


Subject(s)
Phlebotomy , Varicose Veins , Humans , Leg Ulcer/etiology , Leg Ulcer/therapy , Lymphedema/surgery , Lymphedema/therapy , Physical Therapy Modalities , Sclerotherapy/methods , Sclerotherapy/standards , Varicose Veins/diagnosis , Varicose Veins/surgery , Varicose Veins/therapy , Vascular Surgical Procedures , Venous Thrombosis/surgery , Venous Thrombosis/therapy
5.
Wounds ; 23(5): 126-34, 2011 May.
Article in English | MEDLINE | ID: mdl-25881359

ABSTRACT

UNLABELLED: Compression therapy is standard treatment for venous leg ulcers. The authors prefer multi-layer, multi-component, stiff, high-pressure bandages to treat venous leg ulcers. The Unna boot (UB) is an example of this type of bandage. The aim of this study was to compare the effectiveness and tolerability of UB to a new, two-component bandage. METHODS: One hundred (100) patients with venous ulcers were randomized into two groups: group A (n = 50) received UB and group B (n = 50) 3M™ Coban™ 2 Layer Compression System (C2L). All patients were followed weekly for 3 months and then monthly until complete healing was achieved. The primary outcomes were: ulcer healing or surface reduction; pain; and exudate control. The secondary outcomes were: ease of application and removal of the bandage, pressure exerted in the supine and standing position after application and before removal, and bandage comfort. RESULTS: C2L was associated with 100% ulcer healing; 47 out of 50 cases healed within the first 3 months after application of the bandage. Compared with the UB, there was no statistically significant difference. In both groups the effect of compression on pain and overall well being was excellent; pain decreased by 50% within 1-2 weeks and remained low throughout the duration of treatment and overall well being improved significantly. There was no significant difference between the two systems concerning level of comfort. CONCLUSION: C2L proved to be effective in treating venous ulcers due to its stiffness and pressure. Its effectiveness was similar to UB, which is often considered the gold-standard compression device for venous ulcers. This fact, in combination with high tolerability and ease of application and removal, make this new bandage particularly suitable for the treatment of venous leg ulcers. .

6.
Dermatol Surg ; 34(5): 631-9, 2008 May.
Article in English | MEDLINE | ID: mdl-18261104

ABSTRACT

BACKGROUND: The physical characteristics of bandage kits, in which different materials are combined, cannot be predicted by laboratory tests. They can only be assessed in vivo by measuring the interface pressure and calculation of stiffness. OBJECTIVE: The objective was to investigate pressure and stiffness of some widely used multicomponent, multilayer bandages and to investigate the effect of modifications of their components. METHODS AND MATERIALS: Twelve healthy volunteers were investigated. Interface pressure and stiffness were measured in the lying and standing position after application of four-layer elastic bandage (Profore, Smith & Nephew, Hull, UK), two-layer elastic bandage (Proguide, Smith & Nephew), and four-layer short-stretch bandage (Rosidal sys, Lohmann & Rauscher GmbH, Neuwied, Germany) applied according to the manufacturer's recommendations and after some modifications of the padding layer. RESULTS: Both Profore, made up of elastic, and Rosidal sys, made up of inelastic components, fulfill the criteria for bandages with high stiffness. The stiffness of Proguide, consisting of elastic components, is in a gray zone between elastic and inelastic materials. Altering the padding layers changes the stiffness of these bandages completely. CONCLUSION: Pressure and stiffness of composite bandage kits differ from the physical properties of their components. Modifying the padding layers leads to a change of these physical properties that can only be assessed by in vivo tests on the human leg.


Subject(s)
Bandages , Biocompatible Materials , Elasticity , Equipment Design , Humans , Pressure
7.
Int Wound J ; 2(4): 307-14, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16618317

ABSTRACT

Debridement plays an essential role in the wound-bed preparation of necrotic and sloughy ulcers, being a mandatory step to achieve a well-debrided bed, proceeding towards healing. This study reports our experience with Versajet [Versajet Hydrosurgery System (Smith & Nephew, Hull, UK)], a new device for the debridement of exudating ulcers, based on Fluidjet technology, which excises and aspirates the unwanted tissue by using the Venturi effect. In a 10-month time period, a total of 68 patients, out of a setting of 167 patients, hospitalised as affected by chronic, hard-to-heal leg ulcers, stuck in the inflammatory phase, were treated with Versajet. Based on ulcer characteristics and clinical conditions, the remaining 99 patients underwent traditional debridement with moist dressings (controls). In the majority of Versajet-treated cases (46), an adequately debrided wound bed was achieved with one operative procedure; two and three procedures were required in 17 and 5 patients, respectively. Almost all the procedures were performed in the ward at the patient's bedside. This procedure is quick (mean time per treatment is about 5 minutes); when compared with a traditional treatment with moist dressings, Versajet considerably shortens the in-hospital stay and promotes a quicker healing process. When used by an experienced surgeon, Versajet allows a selective debridement, as it makes it possible to remove only the tissue centred in the working end and spare the healthy tissue. Debriding with Versajet is highly effective in reducing the bacterial load of the ulcer bed. The pain caused by Versajet is well tolerated, especially when set for gentle debridement. If multiple treatments are required, the combined use with moist dressings is synergistic, as the dressings soften the necrotic tissue, thus facilitating the following Versajet debridement. The results indicate that Versajet offers more precision than standard mechanical debridement and, at high settings, offers an alternative to surgical debridement.


Subject(s)
Debridement/instrumentation , Leg Ulcer/therapy , Water , Wound Healing , Adult , Aged , Aged, 80 and over , Bandages , Equipment Design , Female , Humans , Leg Ulcer/pathology , Male , Middle Aged , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...